Rational immunotherapy in the combination treatment of community-acquired pneumonia

Abstract

The article analyzes the immunomodulatory therapy as part of pathogenetic treatment of community-acquired pneumonia. Immunological monitoring of patients with severe community-acquired pneumonia demonstrated a disbalance of natural resistance factors, cellular component of immune system and humoral stress factor, which required immunotherapy. Immunomodulatory therapy included azoximer bromide (Polyoxidonium) according to the prescribed regimen and demonstrated immunological efficacy.

Keywords

• внебольничная пневмония
• иммунокоррекция
• иммунопатогенез
• азоксимера бромид (полиоксидоний)
• community-acquired pneumonia
• immunotherapy
• immunopathogenesis
• azoximer bromide (polyoxidonium)